Ultragenyx Pharmaceutical total liabilities and share holders equity for the quarter ending June 30, 2024 was $1.618B, a 23.42% increase year-over-year.
Ultragenyx Pharmaceutical total liabilities and share holders equity for 2023 was $1.491B, a 3.52% decline from 2022.
Ultragenyx Pharmaceutical total liabilities and share holders equity for 2022 was $1.545B, a 1.51% increase from 2021.
Ultragenyx Pharmaceutical total liabilities and share holders equity for 2021 was $1.522B, a 13.48% decline from 2020.
Ultragenyx Pharmaceutical Total Liabilities and Share Holders Equity 2012-2024 | RARE